Is behavioral sensitization to 3,4-methylenedioxymethamphetamine (MDMA) mediated in part by cholinergic receptors?

Behavioural Brain Research

Volumn 244, Issue , 2013, Pages 116-119

  Lettfuss, Nadine Y ^a   Seeger Armbruster, Sonja ^a   von Ameln Mayerhofer, Andreas ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Acetylcholine receptors; Atropine; Behavioral sensitization; Expression of sensitization; MDMA; Mecamylamine

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ATROPINE; MECAMYLAMINE; MUSCARINIC RECEPTOR; NICOTINIC RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIORAL SENSITIZATION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; HORIZONTAL ACTIVITY; HYPERLOCOMOTION; LOCOMOTION; MALE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REARING; SENSITIZATION;

ANIMALS; ATROPINE; CENTRAL NERVOUS SYSTEM SENSITIZATION; MALE; MECAMYLAMINE; MOTOR ACTIVITY; MUSCARINIC ANTAGONISTS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NICOTINIC ANTAGONISTS; RATS; RECEPTORS, MUSCARINIC;

EID: 84874709667     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.01.033     Document Type: Article

References (28)

1. Capela J.P., Carmo H., Remiao F., Bastos M.L., Meisel A., Carvalho F. Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Molecular Neurobiology 2009, 39:210-271.
2. Acquas E., Marrocu P., Pisanu A., Cadoni C., Zernig G., Saria A., et al. Intravenous administration of ecstasy (3,4-methylendioxymethamphetamine) enhances cortical and striatal acetylcholine release in vivo. European Journal of Pharmacology 2001, 418:207-211.
3. Nair S.G., Gudelsky G.A. 3,4-Methylenedioxymethamphetamine enhances the release of acetylcholine in the prefrontal cortex and dorsal hippocampus of the rat. Psychopharmacology (Berl) 2006, 184:182-189.
4. Nair S.G., Gudelsky G.A. 3,4-Methylenedioxymethamphetamine (MDMA) enhances the release of acetylcholine by 5-HT4 and D1 receptor mechanisms in the rat prefrontal cortex. Synapse 2005, 58:229-235.
5. Day J., Fibiger H.C. Dopaminergic regulation of cortical acetylcholine release. Synapse 1992, 12:281-286.
6. Battaglia G., Brooks B.P., Kulsakdinun C., De Souza E.B. Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites. European Journal of Pharmacology 1988, 149:159-163.
7. Spanos L.J., Yamamoto B.K. Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat. Pharmacology Biochemistry & Behavior 1989, 32:835-840.
8. Kalivas P.W., Duffy P., White S.R. MDMA elicits behavioral and neurochemical sensitization in rats. Neuropsychopharmacology 1998, 18:469-479.
9. Mayerhofer A., Schmidt W.J. Development of sensitization of behavioural effects of 3,4-methylenedioxymethamphetamine (MDMA). European Journal of Neuroscience 2000, 12(Suppl. 11).
10. Atkins K., Burks T., Swann A.C., Dafny N. MDMA (ecstasy) modulates locomotor and prefrontal cortex sensory evoked activity. Brain Research 2009, 1302:175-182.
11. Gold L.H., Koob G.F. MDMA produces stimulant-like conditioned locomotor activity. Psychopharmacology (Berl) 1989, 99:352-356.
12. Morley K.C., Arnold J.C., McGregor I.S. Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2005, 29:648-657.
13. Stewart J., Badiani A. Tolerance and sensitization to the behavioral effects of drugs. Behavioral Pharmacology 1993, 4:289-312.
14. von Ameln N., von Ameln-Mayerhofer A. Atypical development of behavioural sensitization to 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') in adolescent rats and its expression in adulthood: role of the MDMA chirality. Addiction Biology 2010, 15:35-44.
15. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Research 1986, 396:157-198.
16. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Research Brain Research Reviews 1993, 18:247-291.
17. Stolerman I.P., Garcha H.S., Mirza N.R. Dissociations between the locomotor stimulant and depressant effects of nicotinic agonists in rats. Psychopharmacology (Berl) 1995, 117:430-437.
18. Museo E., Wise R.A. Locomotion induced by ventral tegmental microinjections of a nicotinic agonist. Pharmacology Biochemistry & Behavior 1990, 35:735-737.
19. Ericson M., Olausson P., Engel J.A., Soderpalm B. Nicotine induces disinhibitory behavior in the rat after subchronic peripheral nicotinic acetylcholine receptor blockade. European Journal of Pharmacology 2000, 397:103-111.
20. Nisell M., Nomikos G.G., Svensson T.H. Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affects accumbal dopamine release. Pharmacology and Toxicology 1994, 75:348-352.
21. Koob G.F. Neural mechanisms of drug reinforcement. Annals of the New York Academy of Sciences 1992, 654:171-191.
22. Nestler E.J. Is there a common molecular pathway for addiction. Nature Neuroscience 2005, 8:1445-1449.
23. Ohmori T., Abekawa T., Koyama T. Scopolamine prevents the development of sensitization to methamphetamine. Life Sciences 1995, 56:1223-1229.
24. Heidbreder C.A., Shippenberg T.S. Evidence for an involvement of muscarinic cholinergic systems in the induction but not expression of behavioral sensitization to cocaine. Synapse 1996, 24:182-192.
25. Laviolette S.R., Priebe R.P.M., Yeomans J.S. Role of the laterodorsal tegmental nucleus in scopolamine- and amphetamine-induced locomotion and stereotypy. Pharmacology Biochemistry and Behavior 2000, 65:163-174.
26. Schoffelmeer A.N., De Vries T.J., Wardeh G., van de Ven H.W., Vanderschuren L.J. Psychostimulant-induced behavioral sensitization depends on nicotinic receptor activation. Journal of Neuroscience 2002, 22:3269-3276.
27. Pickens C.L., Airavaara M., Theberge F., Fanous S., Hope B.T., Shaham Y. Neurobiology of the incubation of drug craving. Trends in Neurosciences 2011, 34:411-420.
28. Takahashi S., Fornari R.V., Quadros I.M., Oliveira M.G., Souza-Formigoni M.L. Does scopolamine block the development of ethanol-induced behavioral sensitization. Alcoholism: Clinical and Experimental Research 2007, 31:1482-1489.